Williams Cancer Institute

Dr. Jason R Williams, MD, DABR

Director of Interventional Oncology and Immunotherapy
at the Williams Cancer Institute.

Author of “The Immunotherapy Revolution”

American Radiologist and Interventional Oncologist

Chemotherapy, and radiation are not only extreme but can be just as painful and dangerous as cancer

Jason Russell Williams (born April 8, 1974) is an American Radiologist and Interventional Oncologist specializing in image-guided procedures for cancer and immunotherapy. He is considered a pioneer in intratumoral immunotherapy and cancer ablative technologies such as cryoablation and RFA. He is involved in research with immunotherapy drug development and image-guided devices to treat cancer.

He was the winner of the 2019 Vince Lombardi “Leaders for a Cure Award.” He has won 2007 Telly and Communicator awards for his video work on RFA. He won the RSNA (Radiological Society of North America) Research fellow award in 2004. He is an American board-certified radiologist and author of “The Immunotherapy Revolution, The Best New Hope for Saving Cancer Patients’ Lives.” He is the founder of Williams Cancer Institute and an adjunct professor at Case Western Reserve University.


Winner of the 2019 Vince Lombardi Cancer Foundation, Leaders for a Cure Award.

Dr Jason Williams


Interventional Oncology and Immunotherapy, Williams Cancer Institute.

First In Procedures


Breast ablation


First in human, combination intratumoral Yervoy/Opdivo with tumor ablation


First in human, intra-arterial infusion into liver tumors, a combination Yervoy/Opdivo


Combination ablation intratumoral IL2, Interferon


First in human, intratumoral combination Yervoy/Opdivo/CpG/PV-10


First in human, intratumoral OX40/CpG agonist


Medical School: Louisiana State University Health Sciences Center.

Internship: Internal Medicine, University South Alabama.

Residency: Radiology, University of South Alabama.
Certifications and Additional

Training: Board Certified by American Board of Radiology, Interventional Oncology, Interventional Spine, Nuclear Medicine.

MQSA (Breast Imaging), ACLS, PALS.

Adjunct Professor: Case Western Reserve University, Cleveland, OH.

Radiological Society of North America Resident/Fellow of the year award 2002.

2007 Telly award.


Combined use of image guided ablation with immune checkpoint inhibitors, Ipilimumab and Nivolumab (anti CTLA-4 and PD-1).

Intra-tumoral PV-10 combined with cryoablation and AblationVax.

Intra-tumoral Toll-like receptor agonist (TLR) imiquimod and CpG combined with Cryoablation and immune checkpoint inhibitors.

Implantable IDO inhibitor pellet (Indoximod) combined with Cryoablation and immune checkpoint inhibitors.

Intra-arterial 3-bromopyruvate combined with intra-arterial immune checkpoint inhibitors Ipilimumab and Nivolumab.

Intra-arterial hepatic infusion of immunotherapy, Nivolumab and Ipilimumab.

Cryoablation of cancer combined with intra-tumoral injection of Montanide.